Literature DB >> 9917186

How do we assess the value of surveillance techniques in ulcerative colitis?

C N Bernstein1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9917186     DOI： 10.1016/s1091-255x(98)80069-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  22 in total

1.  Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.

Authors:  R Löfberg; O Broström; P Karlén; B Tribukait; A Ost
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

2.  Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia.

Authors:  A J Woolrich; M D DaSilva; B I Korelitz
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

3.  Cancer surveillance in ulcerative colitis.

Authors:  F W Nugent; R C Haggitt; P A Gilpin
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

4.  Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.

Authors:  B A Lashner; S V Kane; S B Hanauer
Journal:  Am J Gastroenterol       Date:  1990-09       Impact factor: 10.864

5.  Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.

Authors:  M Leidenius; I Kellokumpu; A Husa; M Riihelä; P Sipponen
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance.

Authors:  B A Taylor; J H Pemberton; H A Carpenter; K E Levin; K W Schroeder; D R Welling; M P Spencer; A R Zinsmeister
Journal:  Dis Colon Rectum       Date:  1992-10       Impact factor: 4.585

7.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

Authors:  C E Rubin; R C Haggitt; G C Burmer; T A Brentnall; A C Stevens; D S Levine; P J Dean; M Kimmey; D R Perera; P S Rabinovitch
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

8.  Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years duration.

Authors:  M Vilien; M J Jørgensen; Q Ouyang; P Schlichting; J Linde; P Riis; V Binder
Journal:  J Intern Med       Date:  1991-09       Impact factor: 8.989

9.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.

Authors:  J E Lennard-Jones; D M Melville; B C Morson; J K Ritchie; C B Williams
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

10.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.

Authors:  D M Melville; J R Jass; B C Morson; D J Pollock; P I Richman; N A Shepherd; J K Ritchie; S B Love; J E Lennard-Jones
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466
View more
  4 in total

Review 1.  The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance.

Authors:  Martin S Friedlich; Maha Guindi; Hartley S Stern
Journal:  Can J Surg       Date:  2004-06       Impact factor: 2.089

2.  Clinical presentation and diagnosis of intestinal adenocarcinoma in Crohn's disease: analysis of clinical predictors and of the life-time risk.

Authors:  Cesare Ruffolo; Marco Scarpa; Lino Polese; Francesco E D'Amico; Riccardo Boetto; Anna Pozza; Renata D'Incà; Davide Checchin; Giacomo Carlo Sturniolo; Nicolò Bassi; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2010-07-14       Impact factor: 3.452

Review 3.  Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.

Authors:  Samir A Shah; David T Rubin; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2014-09

4.  Intestinal cancer in patients with Crohn's disease.

Authors:  Sabine Kersting; Matthias Bruewer; Mike G Laukoetter; Emile M Rijcken; Rudolf Mennigen; Horst Buerger; Norbert Senninger; Christian F Krieglstein
Journal:  Int J Colorectal Dis       Date:  2006-07-18       Impact factor: 2.571
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.